Skip to main content
×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

GE Healthcare and Theragnostics announce global commercial partnership for late stage PSMA diagnostic for prostate cancer

October 09, 2019
  • Theragnostics’ novel PET tracer, GalliProst, will help visualize prostate cancer to enable personalized treatment.
  • The two companies will leverage their combined scientific, commercial and market access expertise to work towards a commercial launch.

Chalfont St Giles, UK – October 9th 2019 GE Healthcare and Theragnostics have entered into a global commercial partnership for a new Prostate-Specific Membrane Antigen (PSMA) PET/CT imaging agent.

For media inquiries, please contact:

David Morris
Communications Director, Pharmaceutical Diagnostics
GE Healthcare
+44 7920591370
[email protected]
Europe/London

business unit
tags
Press Release

屋内測位システム「OWLiQ™ tracking」が、 病院IoT化構想「Brilliant Hospital」に採用

October 09, 2019

~製造現場の見える化ノウハウを活用し医療現場の生産性を向上~

【東京 2019年10月9日】GEヘルスケア・ジャパン株式会社(本社:東京都日野市、代表取締役社長兼CEO:多田 荘一郎、以下「GEヘルスケア」)と株式会社村田製作所(本社:京都府長岡京市、代表取締役会長兼社長:村田 恒夫、以下「村田製作所」)は、GEヘルスケアの病院IoT化構想「Brilliant Hospital」に村田製作所の屋内測位システム「OWLiQ™ tracking」を、採用したことをお知らせします。両社は医療現場における医療設備の稼働状況の見える化など、業務効率化や生産性向上に向けた取り組みを協同で行っています。


business unit
Press Release

GE brings one of the leading universities to Debrecen

October 02, 2019

MIT (Massachussetts Institute of Technology), one of the best universities in the world launches its MIT Catalyst program in collaboration with GE Healthcare at first in the region in Hungary at the University of Debrecen. The Hungarian Hub formed with the support of GE will create a European-Transatlantic partnership enabling the creation and support of needs-driven clinical research projects in healthcare.


business unit
Press Release

A GE Debrecenbe hozza a világ egyik vezető egyetemét

October 02, 2019

A világ vezető egyetemei közé tartozó MIT (Massachussetts Institute of Technology) a régióban először Magyarországon, a GE Healthcare-rel együttműködve a Debreceni Egyetemen indítja el a MIT-Catalyst programját. A GE támogatásával létrejövő magyar központtal egy olyan európai-transzatlanti partnerség jön létre, amely lehetőséget teremt a valós klinikai igényeket kielégítő egészségügyi kutatási projektek létrehozására és támogatására.


business unit
Press Release

GEヘルスケア・ジャパン、Point of Care向け超音波診断装置「Venue Go」の発売を開始

October 01, 2019

医療課題の解決に取り組むヘルスケアカンパニー、GEヘルスケア・ジャパン株式会社(本社:東京都日野市、代表取締役社長兼CEO:多田 荘一郎、以下GEヘルスケア)は、患者のいるベッドサイドで検査・診断するPoint of Care向け超音波診断装置の新製品「Venue Go(ベニューゴー)」を 10月1日に発売開始します。


business unit
Press Release

GE HEALTHCARE LAUNCHES CELL DIVE FOR MORE PRECISE CELL BIOMARKER ANALYSIS

September 26, 2019
  • Developed by scientists for scientists – first patent issued 2009 for this product
  • Flexibility of system allows for custom biomarker panel design and whole slide imaging
  • Precise image registration enables spatial and quantititative biomarker analysis

(Paris, France and Seattle, Washington) September 26, 2019  - GE Healthcare launches Cell DIVE™ multiplexed imaging, an anti-body based solution that builds on years of research and development to transform immuno-oncology. 


business unit
Press Release

GE Healthcare expands oncology PET tracer portfolio – aims to improve patient response rates to immunotherapies

September 24, 2019
  • Partnering with multiple companies to develop targeted PET imaging tracers to better predict and monitor individual patient response to immunotherapies
  • PET tracers would help increase patient response rates which currently average between 20-40%
  • Initially PET tracers would support pharma companies to enhance clinical trials enabling speed-to-market for immunotherapies

Chalfont St Giles, UK –September 24 2019 GE Healthcare is partnering with multiple companies and academic institutions to develo

For media inquiries, please contact:

David Morris
Communications Director, Pharmaceutical Diagnostics
GE Healthcare
+44 7920591370
[email protected]
Europe/London

business unit
Press Release

GE Healthcare launches super-resolution microscope

September 18, 2019

• Gives fast, deep and clear images for live observation over long periods

• Scientists can study a larger range of applications thanks to multiple imaging modes integrated on one device – saving the need for multiple instruments.

• EDGE Confocal imaging allows deeper imaging into samples, tissues or organisms


business unit
Press Release

GE Healthcare Receives FDA Clearance of First Artificial Intelligence Algorithms Embedded On-Device to Prioritize Critical Chest X-ray Review

September 12, 2019
  • Helps radiologists prioritize critical cases with a suspected pneumothorax – a type of collapsed lung – by immediately flagging critical cases to radiologists for triage, which could drastically cut the average review time from up to eight hours[1]
  • Offers first-of-its-kind automated AI quality check features that detect acquisition errors, flagging images for technologist review and allowing them to make corrections before they go to radiologists for review

WAUKESHA, Wis., September 12, 2019

For media inquiries, please contact:

Margaret Steinhafel
1 608 381 8829
[email protected]

business unit
tags
Press Release

GE Healthcare and NIBRT Join Forces to Boost Talent Growth in Single-Use Bioprocessing

September 11, 2019

Marlborough, MA, United States and Dublin, Ireland – September 11, 2019 – GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland are combining their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing.


business unit
Subscribe to GE Healthcare